GlassScriptPhysician profile
Stephen Albert Loper
NPI 1164666061
$4,571.54
in general payments reported to CMS, 2019-2025
34 companies · $1,555 in 2025
The $1,555 reported for 2025 was more than what 94% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $798 · 2022: $973 · 2023: $760 · 2024: $486 · 2025: $1,555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,696 · Education: $105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,696.10 |
| Education | $104.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $585.75 | 2021-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $471.96 | 2021-2023 | Xiaflex, Aveed |
| Abbvie INC. | $391.16 | 2021-2025 | |
| 180 Medical, INC. | $351.93 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $285.58 | 2023-2025 | Gemtesa, Orgovyx |
| Bayer Healthcare Pharmaceuticals INC. | $268.99 | 2021-2025 | |
| Ferring Pharmaceuticals INC. | $225.65 | 2024-2025 | Adstiladrin |
| Endo USA, INC. | $205.94 | 2024-2025 | Xiaflex, Aveed |
| Janssen Biotech, INC. | $202.88 | 2021-2025 | Erleada, Carvykti, Rybrevant |
| Pfizer INC. | $192.27 | 2021-2025 | |
| Boston Scientific Corporation | $172.19 | 2021-2022 | |
| Procept Biorobotics Corporation | $158.23 | 2024-2025 | Aquabeam System |
| Antares Pharma, INC. | $108.99 | 2021-2022 | |
| Coloplast Corp | $93.32 | 2023 | Altis, Speedicath |
| Travere Therapeutics, INC. | $87.19 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $84.66 | 2021-2023 | |
| Dendreon Pharmaceuticals LLC | $69.51 | 2021-2022 | |
| Laborie Medical Technologies Corp. | $68.35 | 2023-2025 | |
| Teleflex LLC | $67.44 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $59.52 | 2021-2025 | Oxlumo |
| Myriad Genetic Laboratories, INC. | $59.40 | 2021-2023 | Prolaris |
| Accord Healthcare, INC. | $58.45 | 2025 | |
| Urovant Sciences INC | $57.89 | 2022 | |
| Axonics, INC. | $36.39 | 2021-2024 | Bulkamid, Axonics |
| Urogen Pharma, INC. | $33.30 | 2022-2025 | |
| Medtronic, INC. | $31.66 | 2024-2025 | Interstim |
| Merck Sharp & Dohme LLC | $26.57 | 2025 | |
| Verity Pharmaceuticals INC. | $19.92 | 2025 | Tlando |
| Civco Medical Instruments | $19.12 | 2024 | |
| Allergan, INC. | $18.71 | 2021 | |
| Olympus America INC. | $16.08 | 2025 | Itind System |
| Innovation Technologies INC | $15.87 | 2024 | Irrisept |
| Intuitive Surgical, INC. | $15.19 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $11.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Loper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.